Inventor · disambiguated record
Heather Finlay
Also filed as: FINLAY HEATHER · FINLAY HEATHER J · FINLAY HEATHER JANE
46 granted patents·8 pending applications·540 citations·filing 1999–2025
98Inventor score
Files withBRISTOL MYERS SQUIBB CO46AGIOS PHARMACEUTICALS INC2ICAGEN INC2SALVATI MARK E2JOHNSON JAMES A1
Top patents by PatentIndex Score
54 records- 0197US7005436B2Heterocyclo inhibitors of potassium channel functionICAGEN INC·Filed 2003·Granted Feb 28, 2006·149 cites·15 claims
- 0296US6511977B1Potassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jan 28, 2003·46 cites·11 claims
- 0396US6150356APotassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Nov 21, 2000·73 cites·14 claims
- 0495US7157451B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 2, 2007·70 cites·15 claims
- 0594US6706720B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Mar 16, 2004·60 cites·21 claims
- 0693US7915410B2Acyclic IKur inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 29, 2011·20 cites·2 claims
- 0792US9822096B2Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 21, 2017·8 cites·20 claims
- 0891US8575184B2Quinazolines as potassium ion channel inhibitorsJOHNSON JAMES A·Filed 2010·Granted Nov 5, 2013·16 cites·40 claims
- 0988US11919915B2Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·30 claims
- 1088US9458114B2Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 4, 2016·9 cites·18 claims
- 1188US7202253B2Cycloalkyl inhibitors of potassium channel functionICAGEN INC·Filed 2004·Granted Apr 10, 2007·27 cites·9 claims
- 1287US7790770B2Heterocyclic CETP inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 7, 2010·10 cites·25 claims
- 1385US6881753B2Potassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 19, 2005·10 cites·7 claims
- 1484US10676460B2Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 9, 2020·1 cites·15 claims
- 1584US7888376B2Heterocyclic CETP inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 15, 2011·8 cites·17 claims
- 1684US2023322726A1Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1782US7582654B2Heterocyclo inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 1, 2009·4 cites·4 claims
- 1882US2025230144A1Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1981US9242966B2Phthalazines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 26, 2016·3 cites·17 claims
- 2080US10106528B26-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·3 cites·58 claims
- 2180US9050345B2Pyrrolotriazines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 9, 2015·8 cites·19 claims
- 2278US8952180B2Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 10, 2015·2 cites·18 claims
- 2377US6784189B2Potassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 31, 2004·5 cites·11 claims
- 2476US2022324836A1Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2575US11390616B2Apelin receptor agonists and methods of useBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 19, 2022·1 cites·4 claims
- 2675US8357809B2Acyclic IKur inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 22, 2013·2 cites·2 claims
- 2774US11008306B2Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 18, 2021·0 cites·5 claims
- 2874US7541362B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 2, 2009·1 cites·8 claims
- 2972US2023365592A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3071US8304403B2Heterocyclic CETP inhibitorsSALVATI MARK E·Filed 2010·Granted Nov 6, 2012·2 cites·17 claims
- 3170US12168655B2Apelin receptor agonists and methods of useBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Dec 17, 2024·0 cites·14 claims
- 3267US10214511B2Quinazolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 26, 2019·0 cites·15 claims
- 3365US9120794B2Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 1, 2015·0 cites·3 claims
- 3465US2009312307A1Heterocyclo inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 3564US9458164B2Pyrrolopyridazines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 4, 2016·1 cites·15 claims
- 3658US2007142333A1Cycloalkyl inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 3758US2025221966A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3852US2004072880A1Cycloalkyl inhibitors of potassium channel functionFiled 2003·Application pending·0 cites
- 3951US10590113B26-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 17, 2020·0 cites·10 claims
- 4051US8642576B2Heterocyclic CETP inhibitorsSALVATI MARK E·Filed 2012·Granted Feb 4, 2014·0 cites·14 claims
- 4150US9403834B2Pyrrolotriazines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 2, 2016·0 cites·19 claims
- 4246US9169240B2Ketone linked benzothiazole inhibitors of endothelial lipaseBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 27, 2015·0 cites·13 claims
- 4345US9458133B2Isoquinolines as potassium ion channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 4, 2016·0 cites·18 claims
- 4445US8987314B2Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipaseBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 24, 2015·0 cites·16 claims
- 4543US9493412B2Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 15, 2016·0 cites·7 claims
- 4643US9249096B2Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 2, 2016·0 cites·8 claims
- 4743US8993557B2Pyridinedione carboxamide inhibitors of endothelial lipaseBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Mar 31, 2015·0 cites·14 claims
- 4843US8680090B2Sulfonyl containing benzothiazole inhibitors of endothelial lipaseBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 25, 2014·0 cites·12 claims
- 4941US10889565B24-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 12, 2021·0 cites·10 claims
- 5041US10597370B22-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 24, 2020·0 cites·17 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Heather Finlay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →